Table of contents

  1. Front Matter
    Pages i-xii
  2. J. A. Gray, S. A. Whatley, M. Snape
    Pages 13-38
  3. D. G. Grahame-Smith
    Pages 46-55
  4. M. Briley, P. Chopin, C. Moret
    Pages 56-73
  5. J. F. W. Deakin, F. S. Guimarães, M. Wang, J. Hellewell, R. Hensman
    Pages 74-93
  6. J. De Vry, T. Glaser, T. Schuurman, R. Schreiber, J. Traber
    Pages 94-129
  7. L. E. Schechter, F. J. Bolaños, H. Gozlan, A.-M. Laporte, C.-M. Fattaccini, M. Hamon
    Pages 145-153
  8. G. Curzon, E. L. Gibson, A. J. Kennedy, G. A. Kennett, G. S. Sarna, P. Whitton
    Pages 154-167
  9. F. S. Abuzzahab
    Pages 185-189
  10. P. Abadie, J. C. Bisserbe, J. P. Boulenger, J. M. Travere, L. Barre, M. C. Petit et al.
    Pages 203-210
  11. S. E. File, P. K. Hitchcott
    Pages 237-255

About this book

Introduction

This book brings together invited contributions on the current thinking on anxiety, from fundamental research to the development of new anxiolytics. It will be of interest and use to all neuropharmacologists and psychiatrists researching into anxiety.

Keywords

depression kinin neuropharmacology neurotransmitter pathophysiology pharmacology physiology research Serotonin

Editors and affiliations

  • M. Briley
    • 1
  • S. E. File
    • 2
  1. 1.Pierre Fabre MédicamentFrance
  2. 2.Psychopharmacology Research UnitUMDS, Guy’s HospitalLondonUK

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-349-11847-2
  • Copyright Information Macmillan Publishers Limited 1991
  • Publisher Name Palgrave, London
  • eBook Packages Engineering
  • Print ISBN 978-1-349-11849-6
  • Online ISBN 978-1-349-11847-2
  • About this book